Currently, there are 13.33M common shares owned by the public and among those 11.13M shares have been available to trade.
Insiders at the company have transacted a total of 13 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 9 of these insider trades were purchases, accounting for 604,364 shares. Insider sales of the common stock occurred on 4 occasions, with total insider shares sold totaling 124,233 shares.
The company’s stock has a 5-day price change of 4.76% and 38.74% over the past three months. CNVS shares are trading 14.07% year to date (YTD), with the 12-month market performance down to -85.95% lower. It has a 12-month low price of $0.97 and touched a high of $12.00 over the same period. CNVS has an average intraday trading volume of 630.80K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -6.28%, 10.29%, and -24.84% respectively.
Institutional ownership of Cineverse Corp (NASDAQ: CNVS) shares accounts for 8.20% of the company’s 13.33M shares outstanding.
It has a market capitalization of $20.53M and a beta (3y monthly) value of 1.45. The earnings-per-share (ttm) stands at -$0.98. Price movements for the stock have been influenced by the stock’s volatility, which stands at 26.93% over the week and 14.86% over the month.
Analysts forecast that Cineverse Corp (CNVS) will achieve an EPS of $CNBS for the current quarter, $24.08 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Annovis Bio, Inc. while analysts give the company a high EPS estimate of $Cineverse Corp. Comparatively, EPS for the current quarter was $Novartis AG a year ago. Earnings per share for the fiscal year are expected to increase by 23.89%, and 25.58% over the next financial year. EPS should shrink at an annualized rate of 10.00% over the next five years, compared to 41.24% over the past 5-year period.
